• Red Blood Cell Lysis Buffer: Practical Workflows

  2026-08-19

  Build cleaner mammalian blood sample preparation workflows for flow cytometry, nucleic acid extraction, protein assays, and cell culture. This guide explains selective erythrocyte removal, practical starting conditions, assay-specific optimization, and troubleshooting for Red Blood Cell Lysis Buffer.

• Resiquimod (R-848) in Ablation Workflows

  2026-08-18

  Resiquimod (R-848) connects TLR7/8-driven innate immune activation with practical tumor-ablation and hydrogel-delivery workflows. This guide explains stock preparation, assay controls, thermal-protection testing, and troubleshooting for translating free-compound experiments into localized chemo-immunomodulation.

• ATRX-Deficient Glioma and RTK Inhibitor Sensitivity

  2026-08-18

  The reference study identifies a genotype-linked vulnerability in high-grade glioma: cells lacking the chromatin remodeler ATRX show increased sensitivity to multi-targeted receptor tyrosine kinase and PDGFR inhibitors. Its combination data further suggest that ATRX status may help interpret RTK inhibitor trials and guide temozolomide-based experimental strategies.

• Azilsartan Medoxomil Monopotassium: Assay Guide

  2026-08-17

  Build reproducible AT1-receptor assays with Azilsartan medoxomil monopotassium (TAK 491), from DMSO stock preparation through washout and signaling readouts. The workflow emphasizes sustained antagonism, concentration control, and translational comparison without confusing clinical evidence with bench-level potency.

• miR-196a, MYC, and EAC Aggressiveness

  2026-08-17

  García-Castillo et al. identify miR-196a as a functional driver of esophageal adenocarcinoma aggressiveness rather than only a progression marker. Their data connect miR-196a to NFKBIA loss, VCP downregulation, c-MYC accumulation, TERT activation, epithelial-to-mesenchymal transition, and increased motility, while tissue analysis supports the relevance of this axis in Barrett’s esophagus.

• XAV-939: From Tankyrase Biology to Translation

  2026-08-16

  XAV-939, also known as NVP-XAV939, offers a mechanistically defined way to interrogate tankyrase-driven control of Wnt/β-catenin and Hippo signaling. This article connects pathway biology with practical assay design and translational strategy across cancer research, fibrotic disease research, and bone biology.

• Pazopanib (GW-786034): ATRX-Aware RTK Assays

  2026-08-15

  Pazopanib (GW-786034) offers a powerful way to study VEGF signaling pathway dependence, angiogenesis inhibition, and genotype-linked drug sensitivity. This guide develops an ATRX-aware assay strategy that separates direct RTK pharmacology from broader tumor growth suppression.

• Cx43/NF-κB Control of AngII-Driven Macrophage Polarization

  2026-08-14

  The reference study shows that angiotensin II drives RAW264.7 macrophages toward an M1-like inflammatory state through a connexin 43–NF-κB signaling axis. By combining molecular profiling with pharmacological inhibition of Cx43 and NF-κB, the work provides a mechanistic framework for studying connexin-dependent inflammation in cardiovascular disease while also defining important limits for translation to other systems.

• BRD4–RAC1 Co-targeting in Breast Cancer

  2026-08-14

  The 2021 study identifies combined BRD4 and RAC1 inhibition as a context-dependent strategy for suppressing breast cancer growth, stemness, migration, and tumorigenesis. Its mechanistic contribution is the connection of this combination to the c-MYC–G9a–FTH1 axis and HDAC1-associated chromatin regulation, providing a framework for interpreting multi-layer epigenetic and oncogenic dependencies.

• Gramine, CUL3–MTDH, and TNBC Ferroptosis

  2026-08-13

  The reference study identifies Gramine as a candidate ferroptosis inducer that suppresses triple-negative breast cancer through a previously underexplored CUL3–MTDH regulatory axis. By combining target-engagement assays, ferroptosis phenotyping, genetic rescue, and xenograft models, the work connects CUL3-mediated MTDH ubiquitination with therapeutic responses in TNBC research.

• Tacrolimus (FK506) Workflow for Calcineurin Studies

  2026-08-13

  Tacrolimus (FK506) provides a high-potency, mechanism-defined way to interrogate FKBP12–calcineurin control of T-cell activation and cytokine release. This workflow connects careful solvent handling and dose-response design with transplantation immunology research, autoimmune disease models, and translational immune-response studies.

• PD 173074: From MIR9 Biology to Causal Assays

  2026-08-12

  PD 173074 provides a precise pharmacological probe for testing whether MIR9-associated FGFR1 activation is functionally important in acute lymphoblastic leukemia. This article translates the key evidence into a causal assay framework covering pathway validation, controls, dosing logic, and interpretation.

• HotStart 2X Green qPCR Master Mix in Endometriosis

  2026-08-12

  A translational framework for using SYBR Green qPCR to validate the FBLN1–EFEMP1–ferroptosis axis in endometriosis while distinguishing transcript-level evidence from functional mechanism.

• Dual-Network Microgels for Intervertebral Disc Degeneration

  2026-08-11

  The reference study develops an elastic dual-network microsphere that combines sustained miR-155/COS delivery with strontium–EGCG metal-phenolic networks to address inflammation, oxidative stress, and nucleus pulposus cell apoptosis in intervertebral disc degeneration. Its stimulus-responsive design links mechanical stability with oxidative-environment-triggered release, offering a useful framework for integrating biomaterial mechanics and multi-pathway biological regulation.

• Sunitinib Experimental Workflows for Cancer Research

  2026-08-11

  Build reproducible Sunitinib assays that connect RTK inhibition with angiogenesis, apoptosis, cell-cycle control, and treatment resistance. A focused workflow for renal cell carcinoma models also translates TRIB3 knockdown and ferroptosis findings into practical mechanistic experiments.

8355 records 4/557 page Previous Next 12345 下5页 Last page